In the News

COVID-19 guidance released for managing IBD patients, endoscopic procedures

The American Gastroenterological Association released new guidance for clinicians caring for patients with inflammatory bowel disease (IBD) and those performing endoscopic procedures, and two recent studies looked at GI symptoms in patients with COVID-19.

Antibiotics may not reduce length of stay in patients hospitalized for uncomplicated diverticulitis

A randomized trial found that median length of hospital stay was 40.0 hours in the antibiotic group and 45.8 hours in the placebo group, with no significant between-group differences in adverse events or readmissions.

Urgent endoscopy did not improve outcomes from acute upper GI bleeds

Thirty-day mortality was slightly lower among high-risk patients who underwent endoscopy for an acute upper GI bleed within 24 hours of a consult instead of within six hours, although the difference was not statistically significant.

MKSAP Quiz: A 1-month history of bloody diarrhea

A 25-year-old woman is evaluated for a 1-month history of intermittent, loose, bloody bowel movements associated with pain in the left lower quadrant before defecation. She reports no fever, chills, night sweats, arthralgia, eye pain, or rash. What is the most likely diagnosis?

Spotlight on IBS treatments

In the past month, several studies looked at potential treatments for irritable bowel syndrome (IBS), including a probiotic strain, psychological therapies, and internet-based versus face-to-face education.

FDA requests removal of all ranitidine from market due to impurity

As a result of the immediate market withdrawal request, ranitidine medications, commonly known by the brand name Zantac, will not be available for new or existing prescription or over-the-counter use in the U.S.